Dawn Allen Sells 74,679 Shares of Haleon plc (LON:HLN) Stock

Haleon plc (LON:HLN) insider Dawn Allen sold 74,679 shares of Haleon stock in a transaction on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.68), for a total transaction of £277,805.88 ($349,837.40).

Haleon Trading Up 2.0 %

HLN stock opened at GBX 379.72 ($4.78) on Monday. The firm’s 50-day moving average is GBX 379.25 and its 200 day moving average is GBX 357.45. The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93. Haleon plc has a 12 month low of GBX 308.37 ($3.88) and a 12 month high of GBX 400.65 ($5.05). The company has a market capitalization of £34.33 billion, a PE ratio of 3,169.17, a P/E/G ratio of 1.49 and a beta of 0.19.

Analyst Ratings Changes

Separately, Berenberg Bank upped their target price on Haleon from GBX 410 ($5.16) to GBX 447 ($5.63) and gave the company a “buy” rating in a research note on Monday, August 5th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.